Skip to main content

Central Nervous System Infections

  • Chapter
  • First Online:
  • 1541 Accesses

Abstract

Central nervous system (CNS) infections occur in up to 15 % of hematology patients, particularly after allogeneic stem cell transplantation (AlloSCT) or in conjunction with neutropenia. The most frequent causative organisms after AlloSCT are Aspergillus spp. and Toxoplasma gondii, which typically cause focal parenchymatous lesions like abscesses or strokes. Meningoencephalitis is less common in these patients and might be related to viruses (mainly human herpesvirus-6 (HHV-6)) but sometimes also to fungi (e.g., Candida spp., Cryptococcus neoformans) or bacteria (e.g., Staphylococcus aureus, coagulase-negative Staphylococcus spp.). Definitive diagnosis of CNS infections, though still often made only at autopsy, is crucial and relies mainly on neuroimaging, cerebrospinal fluid (CSF) analysis, and/or stereotactic biopsy of focal lesions. Empirical or preemptive anti-infective drug therapy should be prompted immediately after obtaining CSF and/or biopsy tissue and adjusted after identifying a causative agent and determining its in vitro susceptibility. CNS infections in hematology patients are still largely associated with a poor prognosis and a mortality rate of up to 90 %. However, particularly the introduction of new antifungal agents with improved pharmacological profiles has led to better outcomes in selected subgroups of patients such as those with CNS aspergillosis.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Andreula CF, Burdi N, Carella A. CNS cryptococcosis in AIDS: spectrum of MR findings. J Comput Assist Tomogr. 1993;17:438–41.

    Article  CAS  PubMed  Google Scholar 

  2. Antinori S, Corbellino M, Meroni L, Resta F, Sollima S, Tonolini M, et al. Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infect. 2013;66:218–38.

    Article  PubMed  Google Scholar 

  3. Biesbroek JM, Verduyn Lunel FM, Kragt JJ, Amelink GJ, Frijns CJ. Culture-negative Candida meningitis diagnosed by detection of Candida mannan antigen in CSF. Neurology. 2013;81:1555–6.

    Article  PubMed  Google Scholar 

  4. Brouwer AE, Rajanuwong A, Chierakul W, Griffin GE, Larsen RA, White NJ, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet. 2004;363:1764–7.

    Article  CAS  PubMed  Google Scholar 

  5. Chaaban S, Wheat LJ, Assi M. Cryptococcal meningitis post autologous stem cell transplantation. Transpl Infect Dis. 2014;16:473–6.

    Article  CAS  PubMed  Google Scholar 

  6. Chakrabarti A, Chatterjee SS, Das A, Panda N, Shivaprakash MR, Kaur A, et al. Invasive zygomycosis in India: experience in a tertiary care hospital. Postgrad Med J. 2009;85:573–81.

    Article  CAS  PubMed  Google Scholar 

  7. Chandramukhi A. Diagnosis of neurotoxoplasmosis by antibody detection in cerebrospinal (CSF) fluid using Latex Agglutination Test and ELISA. J Commun Dis. 2004;36:153–8.

    CAS  PubMed  Google Scholar 

  8. Charlot M, Pialat JB, Obadia N, Boibieux A, Streichenberger N, Meyronnet D, et al. Diffusion-weighted imaging in brain aspergillosis. Eur J Neurol. 2007;14:912–6.

    Article  CAS  PubMed  Google Scholar 

  9. Coker RJ, Viviani M, Gazzard BG, Du Pont B, Pohle HD, Murphy SM, et al. Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. AIDS. 1993;7:829–35.

    Article  CAS  PubMed  Google Scholar 

  10. Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, el Chakrabarti A. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014;20:5–26.

    Article  CAS  PubMed  Google Scholar 

  11. Dannemann B, McCutchan JA, Israelski D, Antoniskis D, Leport C, Luft B, et al. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. Ann Intern Med. 1992;116:33–43.

    Article  CAS  PubMed  Google Scholar 

  12. De Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347:1549–56.

    Article  PubMed  Google Scholar 

  13. Deisenhammer F, Bartos A, Egg R, Gilhus NE, Giovannoni G, Rauer S, EFNS Task Force, et al. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol. 2006;13:913–22.

    Article  CAS  PubMed  Google Scholar 

  14. Denier C, Bourhis JH, Lacroix C, Koscielny S, Bosq J, Sigal R, et al. Spectrum and prognosis of neurologic complications after hematopoietic transplantation. Neurology. 2006;67:1990–7.

    Article  CAS  PubMed  Google Scholar 

  15. Dotis J, Iosifidis E, Roilides E. Central nervous system aspergillosis in children: a systematic review of reported cases. Int J Infect Dis. 2007;11:381–93.

    Article  PubMed  Google Scholar 

  16. Falci DR, Lunardi LW, Ramos CG, Bay MB, Aquino VR, Goldani LZ. Continuous infusion of amphotericin B deoxycholate in the treatment of cryptococcal meningoencephalitis: analysis of safety and fungicidal activity. Clin Infect Dis. 2010;50:e26–9.

    Article  CAS  PubMed  Google Scholar 

  17. Fricker-Hidalgo H, Bulabois CE, Brenier-Pinchart MP, Hamidfar R, Garban F, Brion JP, et al. Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques. Clin Infect Dis. 2009;48:e9–15.

    Article  PubMed  Google Scholar 

  18. Gabelmann A, Klein S, Kern W, Krüger S, Brambs HJ, Rieber-Brambs A, et al. Relevant imaging findings of cerebral aspergillosis on MRI: a retrospective case-based study in immunocompromised patients. Eur J Neurol. 2007;14:548–55.

    Article  CAS  PubMed  Google Scholar 

  19. Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006;50:126–33.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984–1992. Clin Infect Dis. 1994;19:402–8.

    Article  CAS  PubMed  Google Scholar 

  21. Hakko E, Ozkan HA, Karaman K, Gulbas Z. Analysis of cerebral toxoplasmosis in a series of 170 allogeneic hematopoietic stem cell transplant patients. Transpl Infect Dis. 2013;15:575–80.

    Article  CAS  PubMed  Google Scholar 

  22. Hamill RJ, Sobel JD, El-Sadr W, Johnson PC, Graybill JR, Javaly K, et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety. Clin Infect Dis. 2010;51:225–32.

    Article  CAS  PubMed  Google Scholar 

  23. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347:408–15.

    Article  CAS  PubMed  Google Scholar 

  24. Hiraga A, Uzawa A, Shibuya M, Numata T, Sunami S, Kamitsukasa I. Neuroaspergillosis in an immunocompetent patient successfully treated with voriconazole and a corticosteroid. Intern Med. 2009;48:1225–9.

    Article  PubMed  Google Scholar 

  25. Jadhav MP, Bamba A, Shinde VM, Gogtay N, Kshirsagar NA, Bichile LS, et al. Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: a multicentric, randomized controlled trial. J Postgrad Med. 2010;56:71–5.

    Article  CAS  PubMed  Google Scholar 

  26. Katlama C, De Wit S, O’Doherty E, Van Glabeke M, Clumeck N. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis. 1996;22:268–75.

    Article  CAS  PubMed  Google Scholar 

  27. Kazak E, Aslan E, Akalın H, Saraydaroğlu O, Hakyemez B, Erişen L, et al. A mucormycosis case treated with a combination of caspofungin and amphotericin B. J Mycol Med. 2013;23:179–84.

    Article  CAS  PubMed  Google Scholar 

  28. Kish MA, Infectious Diseases Society of America. Guide to development of practice guidelines. Clin Infect Dis. 2001;32:851–4.

    Article  CAS  PubMed  Google Scholar 

  29. Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1995;171:857–63.

    Article  CAS  PubMed  Google Scholar 

  30. Loyse A, Wilson D, Meintjes G, Jarvis JN, Bicanic T, Bishop L, et al. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis. 2012;54:121–8.

    Article  CAS  PubMed  Google Scholar 

  31. Majithiya J, Sharp A, Parmar A, Denning DW, Warn PA. Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei. J Antimicrob Chemother. 2009;63:161–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Maschke M, Dietrich U, Prumbaum M, Kastrup O, Turowski B, Schaefer UW, et al. Opportunistic CNS infection after bone marrow transplantation. Bone Marrow Transplant. 1999;23:1167–76.

    Article  CAS  PubMed  Google Scholar 

  33. Mattiuzzi G, Giles FJ. Management of intracranial fungal infections in patients with haematological malignancies. Br J Haematol. 2005;131:287–300.

    Article  CAS  PubMed  Google Scholar 

  34. Meers S, Lagrou K, Theunissen K, Dierickx D, Delforge M, Devos T, et al. Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation. Clin Infect Dis. 2010;50:1127–34.

    Article  PubMed  Google Scholar 

  35. Muccio CF, Esposito G, Bartolini A, Cerase A. Cerebral abscesses and necrotic cerebral tumours: differential diagnosis by perfusion-weighted magnetic resonance imaging. Radiol Med. 2008;113:747–57.

    Article  CAS  PubMed  Google Scholar 

  36. Mueller-Mang C, Mang TG, Kalhs P, Thurnher MM. Imaging characteristics of toxoplasmosis encephalitis after bone marrow transplantation: report of two cases and review of the literature. Neuroradiology. 2006;48:84–9.

    Article  CAS  PubMed  Google Scholar 

  37. Mulanovich VE, Ahmed SI, Öztürk T, Khokhar FA, Kontoyiannis DP, de Lima M. Toxoplasmosis in allo-SCT patients: risk factors and outcomes at a transplantation center with a low incidence. Bone Marrow Transplant. 2011;46:273–7.

    Article  CAS  PubMed  Google Scholar 

  38. Noguchi T, Yoshiura T, Hiwatashi A, Togao O, Yamashita K, Nagao E, et al. CT and MRI findings of human herpesvirus 6-associated encephalopathy: comparison with findings of herpes simplex virus encephalitis. AJR Am J Roentgenol. 2010;194:754–60.

    Article  PubMed  Google Scholar 

  39. Pagano L, Fianchi L, Caramatti C, D’Antonio D, Melillo L, Caira M, Gruppo Italiano Malattie EMatologiche dell’Adulto Infection Program, et al. Cryptococcosis in patients with hematologic malignancies. A report from GIMEMA-infection. Haematologica. 2004;89:852–6.

    PubMed  Google Scholar 

  40. Pagano L, Valentini CG, Posteraro B, Girmenia C, Ossi C, Pan A, et al. Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). J Chemother. 2009;21:322–9.

    Article  CAS  PubMed  Google Scholar 

  41. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:291–322.

    Article  PubMed  Google Scholar 

  42. Pruitt AA. Central nervous system infections in cancer patients. Semin Neurol. 2004;24:435–52.

    Article  PubMed  Google Scholar 

  43. Reddy P, Davenport R, Ratanatharathorn V, Reynolds C, Silver S, Ayash L, et al. West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2004;33:109–12.

    Article  CAS  PubMed  Google Scholar 

  44. Reed C, Bryant R, Ibrahim AS, Edwards Jr J, Filler SG, Goldberg R, et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008;47:364–71.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Reinwald M, Buchheidt D, Hummel M, Duerken M, Bertz H, Schwerdtfeger R, et al. Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis. PLoS One. 2013;8:e56706.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Roemer E, Blau IW, Basara N, Kiehl MG, Bischoff M, Günzelmann S, et al. Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience. Clin Infect Dis. 2001;32:E1–8.

    Article  CAS  PubMed  Google Scholar 

  47. Rüping MJ, Heinz WJ, Kindo AJ, Rickerts V, Lass-Flörl C, Beisel C, et al. Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother. 2010;65:296–302.

    Article  PubMed  Google Scholar 

  48. Safdieh JE, Mead PA, Sepkowitz KA, Kiehn TE, Abrey LE. Bacterial and fungal meningitis in patients with cancer. Neurology. 2008;70:943–7.

    Article  CAS  PubMed  Google Scholar 

  49. Saha DC, Xess I, Biswas A, Bhowmik DM, Padma MV. Detection of Cryptococcus by conventional, serological and molecular methods. J Med Microbiol. 2009;58:1098–105.

    Article  CAS  PubMed  Google Scholar 

  50. Sánchez-Portocarrero J, Pérez-Cecilia E, Corral O, Romero-Vivas J, Picazo JJ. The central nervous system and infection by Candida species. Diagn Microbiol Infect Dis. 2000;37:169–79.

    Article  PubMed  Google Scholar 

  51. Scarcella A, Pasquariello MB, Giugliano B, Vendemmia M, de Lucia A. Liposomal amphotericin B treatment for neonatal fungal infections. Pediatr Infect Dis J. 1998;17:146–8.

    Article  CAS  PubMed  Google Scholar 

  52. Schmidt M, Sonneville R, Schnell D, Bigé N, Hamidfar R, Mongardon N, et al. Clinical features and outcomes in patients with disseminated toxoplasmosis admitted to intensive care: a multicenter study. Clin Infect Dis. 2013;57:1535–41.

    Article  PubMed  Google Scholar 

  53. Schmidt-Hieber M, Zweigner J, Uharek L, Blau IW, Thiel E. Central nervous system infections in immunocompromised patients: update on diagnostics and therapy. Leuk Lymphoma. 2009;50:24–36.

    Article  PubMed  Google Scholar 

  54. Schmidt-Hieber M, Schwender J, Heinz WJ, Zabelina T, Kühl JS, Mousset S, et al. Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents. Haematologica. 2011;96:142–9.

    Article  PubMed Central  PubMed  Google Scholar 

  55. Schwartz S, Ruhnke M, Ribaud P, Corey L, Driscoll T, Cornely OA, et al. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood. 2005;106:2641–5.

    Article  CAS  PubMed  Google Scholar 

  56. Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, et al. European Confederation of Medical Mycology Working Group on Zygomycosis. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17:1859–67.

    Google Scholar 

  57. Small TN, Leung L, Stiles J, Kiehn TE, Malak SA, O’Reilly RJ, et al. Disseminated toxoplasmosis following T cell-depleted related and unrelated bone marrow transplantation. Bone Marrow Transplant. 2000;25:969–73.

    Article  CAS  PubMed  Google Scholar 

  58. Soeffker G, Wichmann D, Loderstaedt U, Sobottka I, Deuse T, Kluge S. Aspergillus galactomannan antigen for diagnosis and treatment monitoring in cerebral aspergillosis. Prog Transplant. 2013;23:71–4.

    Article  PubMed  Google Scholar 

  59. Sommers LM, Hawkins DS. Meningitis in pediatric cancer patients: a review of forty cases from a single institution. Pediatr Infect Dis J. 1999;18:902–7.

    Article  CAS  PubMed  Google Scholar 

  60. Sostak P, Padovan CS, Yousry TA, Ledderose G, Kolb HJ, Straube A. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology. 2003;60:842–8.

    Article  CAS  PubMed  Google Scholar 

  61. Sun HY, Forrest G, Gupta KL, Aguado JM, Lortholary O, Julia MB, et al. Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients. Transplantation. 2010;90:85–92.

    Article  PubMed  Google Scholar 

  62. Tien RD, Chu PK, Hesselink JR, Duberg A, Wiley C. Intracranial cryptococcosis in immunocompromised patients: CT and MR findings in 29 cases. AJNR Am J Neuroradiol. 1991;12:283–9.

    CAS  PubMed  Google Scholar 

  63. Torre D, Casari S, Speranza F, Donisi A, Gregis G, Poggio A, et al. Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group. Antimicrob Agents Chemother. 1998;42:1346–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  64. Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47:303–27.

    Article  CAS  PubMed  Google Scholar 

  65. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267–84.

    Article  PubMed  Google Scholar 

  66. Tunkel AR, Scheld WM. Acute bacterial meningitis. Lancet. 1995;346:1675–80.

    Article  CAS  PubMed  Google Scholar 

  67. Van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351:1849–59.

    Article  PubMed  Google Scholar 

  68. Van de Beek D, Farrar JJ, de Gans J, Mai NT, Molyneux EM, Peltola H, et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol. 2010;9:254–63.

    Article  PubMed Central  PubMed  Google Scholar 

  69. Vu T, Carrum G, Hutton G, Heslop HE, Brenner MK, Kamble R. Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007;39:705–9.

    Article  CAS  PubMed  Google Scholar 

  70. Walker M, Kublin JG, Zunt JR. Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis. 2006;42:115–25.

    Article  PubMed Central  PubMed  Google Scholar 

  71. Weenink JJ, Weenink AG, Geerlings SE, van Gool T, Bemelman FJ. Severe cerebral toxoplasma infection cannot be excluded by a normal CT scan. Neth J Med. 2009;67:150–2.

    CAS  PubMed  Google Scholar 

  72. Xiao F, Tseng MY, Teng LJ, Tseng HM, Tsai JC. Brain abscess: clinical experience and analysis of prognostic factors. Surg Neurol. 2005;63:442–9.

    Article  PubMed  Google Scholar 

  73. Zuber P, Jacquier P. Epidemiology of toxoplasmosis: worldwide status. Schweiz Med Wochenschr Suppl. 1995;65:19S–22.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgment

The author would like to thank Dr. J. Weirowski for her editorial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin Schmidt-Hieber .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schmidt-Hieber, M. (2015). Central Nervous System Infections. In: Maschmeyer, G., Rolston, K. (eds) Infections in Hematology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44000-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-44000-1_13

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-43999-9

  • Online ISBN: 978-3-662-44000-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics